Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

DE, Spratt; J, Zhang; M, Santiago-Jiménez; RT, Dess; JW, Davis; RB, Den; AP, Dicker; CJ, Kane; A, Pollack; R, Stoyanova; F, Abdollah; AE, Ross; A, Cole; E, Uchio; JM, Randall; H, Nguyen; SG, Zhao; R, Mehra; AG, Glass; LLC, Lam; J, Chelliserry; Plessis M, du; V, Choeurng; M, Aranes; T, Kolisnik; J, Margrave; J, Alter; J, Jordan; C, Buerki; K, Yousefi; Z, Haddad; E, Davicioni; EJ, Trabulsi; S, Loeb; A, Tewari; PR, Carroll; S, Weinmann; EM, Schaeffer; EA, Klein; RJ, Karnes; FY, Feng; PL, Nguyen

doi:10.1200/jco.2017.74.2940

Public

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Shared by NobleBlocks on Nov 29, 2017 • 12:00 AM UTC

Authors:

Spratt DE

Zhang J

Santiago-Jiménez M

Abstract

Purpose It is clinically challenging to integrate genomic-classifier results that report a numeric risk of recurrence into treatment recommendations for localized prostate cancer, which are founded in the framework of risk groups. We aimed to develop a novel clinical-genomic risk grouping system tha...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!